Microbial spectrum and outcomes of endophthalmitis after intravitreal injection versus pars plana vitrectomy

Retina

Volumn 36, Issue 2, 2016, Pages 351-359

  Garg, Sunir J ^a   Dollin, Michael ^a   Storey, Philip ^a   Pitcher, John D ^a   Fang Yen, Natalie Hsiao ^a   Vander, James ^a   Hsu, Jason ^a   Reddy, Sahitya ^a   Vojtko, Joseph ^a   Brady, Christopher J ^a   Decroos, Francis C ^a   Gerstenblith, Adam T ^a   Shah, Rajiv ^a   Haller, Julia A ^a   Brown, Gary C ^a   Fischer, David H ^a   Gupta, Omesh T ^a   Ho, Allen C ^a   Kaiser, Richard S ^a   Maguire, Joseph I ^a   Park, Carl H ^a   Regillo, Carl D ^a   Sivalingam, Arunan ^a   Spirn, Marc J ^a   more..

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

endophthalmitis; intravitreal injection; microbial spectrum; vitrectomy

Indexed keywords

AFLIBERCEPT; AMIKACIN; ANTIBIOTIC AGENT; ATROPINE; BEVACIZUMAB; CEFTAZIDIME; RANIBIZUMAB; STEROID; TRIAMCINOLONE ACETONIDE; VANCOMYCIN; ANGIOGENESIS INHIBITOR; ANTIINFECTIVE AGENT; DRUG COMBINATION; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGE RELATED MACULAR DEGENERATION; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CASE STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DRUG EFFICACY; ENDOPHTHALMITIS; EPIRETINAL MEMBRANE; FEMALE; FOLLOW UP; HUMAN; HYPOPYON; MACULAR DEGENERATION; MACULAR EDEMA; MALE; MICROORGANISM; MIDDLE AGED; MOUTH FLORA; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PARS PLANA VITRECTOMY; POSTOPERATIVE INFLAMMATION; PROLIFERATIVE RETINOPATHY; RETINA DETACHMENT; RETINA MACULA HOLE; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; STREPTOCOCCUS; SURGICAL PATIENT; TREND STUDY; VERY ELDERLY; VISION; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE; ANTAGONISTS AND INHIBITORS; BACTERIUM; COMPARATIVE STUDY; DRUG COMBINATION; DRUG SUBSTITUTION; EYE INFECTIONS, BACTERIAL; INTRAVITREAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINAL DISEASES; VITREOUS BODY;

ADULT; AGED; AGED, 80 AND OVER; AMIKACIN; ANGIOGENESIS INHIBITORS; ANTI-BACTERIAL AGENTS; BACTERIA; CEFTAZIDIME; DRUG COMBINATIONS; DRUG SUBSTITUTION; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; RETINAL DISEASES; RETROSPECTIVE STUDIES; VANCOMYCIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

EID: 84957646883     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000694     Document Type: Article

References (41)

1. Aaberg TM Jr. , Flynn HW Jr. , Schiffman J, Newton J. Noso-comial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology 1998;105:1004-1010.
2. Campbell RJ, Bronskill SE, Bell CM, et al. Rapid expansion of intravitreal drug injection procedures, 2000 to 2008: a population-based analysis. Arch Ophthalmol 2010;128:359-362.
3. Mason JO III, White MF, Feist RM, et al. Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection. Retina 2008;28:564-567.
4. Scott IU, Edwards AR, Beck RW, et al. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 2007;114:1860-1867.
5. Kim SJ, Chomsky AS, Sternberg P Jr. Reducing the risk of endophthalmitis after intravitreous injection. JAMA Ophthal-mol 2013;131:674-675.
6. Simunovic MP, Rush RB, Hunyor AP, Chang AA. Endoph-thalmitis following intravitreal injection versus endophthalmi-tis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. Br J Ophthalmol 2012;96:862-866.
7. McCannel CA. Meta-analysis of endophthalmitis after intra-vitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina 2011;31:654-661.
8. Chen E, Lin MY, Cox J, Brown DM. Endophthalmitis after intravitreal injection: the importance of viridans streptococci. Retina 2011;31:1525-1533.
9. Shah CP, Garg SJ, Vander JF, et al. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology 2011;118:2028-2034.
10. Storey P, Dollin M, Pitcher J, et al. The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection. Ophthalmology 2014;121:283-289.
11. Kuriyan AE, Weiss KD, Flynn HW Jr. , et al. Endophthalmitis caused by streptococcal species: clinical settings, microbiology, management, and outcomes. Am J Ophthalmol 2014; 157:774-780.
12. Kunimoto DY, Kaiser RS. Incidence of endophthalmitis after 20-and 25-gauge vitrectomy. Ophthalmology 2007;114: 2133-2137.
13. Scott IU, Flynn HW Jr. , Dev S, et al. Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomes. Retina 2008;28:138-142.
14. Eifrig CW, Scott IU, Flynn HW Jr. , et al. Endophthalmitis after pars plana vitrectomy: incidence, causative organisms, and visual acuity outcomes. Am J Ophthalmol 2004;138:799-802.
15. Ho PC, Tolentino FI. Bacterial endophthalmitis after closed vitrectomy. Arch Ophthalmol 1984;102:207-210.
16. Cohen SM, Flynn HW Jr. , Murray TG, Smiddy WE. Endoph-thalmitis after pars plana vitrectomy. The Postvitrectomy En-dophthalmitis Study Group. Ophthalmology 1995;102:705-712.
17. Wu L, Berrocal MH, Arevalo JF, et al. Endophthalmitis after pars plana vitrectomy: results of the Pan American Collaborative Retina Study Group. Retina 2011;31:673-678.
18. Gordon DF, Jong BB. Indigenous flora from human saliva. Appl Microbiol 1968;16:428-429.
19. Molander A, Reit C, Dahlen G, Kvist T. Microbiological status of root-filled teeth with apical periodontitis. Int Endod J 1998;31:1-7.
20. Ahrne S, Nobaek S, Jeppsson B, et al. The normal Lactobacil-lus flora of healthy human rectal and oral mucosa. J Appl Microbiol 1998;85:88-94.
21. Moss JM, Sanislo SR, Ta CN. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology 2009;116: 1498-1501.
22. Milder E, Vander J, Shah C, Garg S. Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection. Ophthalmology 2012;119:1420-1424.
23. Yin VT, Weisbrod DJ, Eng KT, et al. Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection. JAMA Ophthalmol 2013;131:456-461.
24. Kim SJ, Toma HS, Midha NK, et al. Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections. Ophthalmology 2010;117:2372-2378.
25. Endophthalmitis Vitrectomy Study Group. Results of the En-dophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995;113:1479-1496.
26. Endophthalmitis Vitrectomy Study Group. Microbiologic factors and visual outcome in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 1996;122:830-846.
27. Lalwani GA, Flynn HW Jr. , Scott IU, et al Acute-onset en-dophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes. Ophthalmology 2008;115:473-476.
28. Veringa E, van Belkum A, Schellekens H. Iatrogenic meningitis by Streptococcus salivarius following lumbar puncture. J Hosp Infect 1995;29:316-318.
29. Trautmann M, Lepper PM, Schmitz FJ. Three cases of bacterial meningitis after spinal and epidural anesthesia. Eur J Clin Mi-crobiol Infect Dis 2002;21:43-45.
30. Wen JC, McCannel CA, Mochon AB, Garner OB. Bacterial dispersal associated with speech in the setting of intravitreous injections. Arch Ophthalmol 2011;129:1551-1554.
31. Doshi RR, Leng T, Fung AE. Reducing oral flora contamination of intravitreal injections with face mask or silence. Retina 2012;32:473-476.
32. Philips BJ, Fergusson S, Armstrong P, et al. Surgical face masks are effective in reducing bacterial contamination caused by dispersal from the upper airway. Br J Anaesth 1992;69: 407-408.
33. McLure HA, Talboys CA, Yentis SM, Azadian BS. Surgical face masks and downward dispersal of bacteria. Anaesthesia 1998;53:624-626.
34. Abell RG, Kerr NM, Allen P, Vote BJ. Intravitreal injections: is there benefit for a theatre setting? Br J Ophthalmol 2012;96: 1474-1478.
35. Casparis H, Wolfensberger TJ, Becker M, et al. Incidence of presumed endophthalmitis after intravitreal injection performed in the operating room: a retrospective multicenter study. Retina 2014;34:12-17.
36. Schachat AP, Rosenfeld PJ, Liesegang TJ, Stewart MW. Endophthalmitis is not a "never event". Ophthalmology 2012; 119:1507-1508.
37. Mao LK, Flynn HW Jr. , Miller D, Pflugfelder SC. Endophthalmitis caused by streptococcal species. Arch Ophthalmol 1992;110:798-801.
38. Moshfeghi AA, Rosenfeld PJ, Flynn HW Jr. , et al. Endoph-thalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center. Retina 2011;31:662-668.
39. Chen E, Ho AC, Garg SJ, et al. Streptococcus mitis endoph-thalmitis presenting as frosted branch angiitis after intravitreal pegaptanib sodium injection. Ophthalmic Surg Lasers Imaging 2009;40:192-194.
40. Goldberg RA, Flynn HW Jr. , Isom RF, et al. An outbreak of Streptococcus endophthalmitis after intravitreal injection of bevacizumab. Am J Ophthalmol 2012;153:204-208.
41. Goldberg RA, Flynn HW Jr. , Miller D, et al. Streptococcus endophthalmitis outbreak after intravitreal injection of bevaci-zumab: one-year outcomes and investigative results. Ophthalmology 2013;120:1448-1453.